Healthcare

Max Healthcare Inst. Limited Q3FY23 Earnings

● Feb 21, 2023

Primary care clinics, multi-specialty hospitals / medical centres, and super-specialty hospitals are the main venues through which Max Healthcare Institute...

Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Transcript

● Feb 17, 2023

Orchid Pharma Ltd (NSE: ORCHPHARMA) Q3 FY23 Earnings Concall dated Feb. 17, 2023 Corporate Participants: Manish Dhanuka — Managing Director Mridul Dhanuka — Executive...

Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript

● Feb 15, 2023

Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada — Managing Director Alpesh Dalal — Chief...

Aster DM Healthcare Limited (ASTERDM) Q3 FY23 Earnings Concall Transcript

● Feb 15, 2023

Aster DM Healthcare Limited (NSE:ASTERDM) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Azad Moopen — Chairman and Managing Director...

Fortis Healthcare Ltd (FORTIS) Q3 FY23 Earnings Concall Transcript

● Feb 14, 2023

Fortis Healthcare Ltd (NSE:FORTIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Anurag Kalra — Senior Vice President, Investor Relations...

Lupin Ltd Q3 FY23 Earnings Conference Call Insights

● Feb 13, 2023

Key highlights from Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Management Update: [00:03:30] LUPIN said it is optimistic of growing...

Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript

● Feb 12, 2023

Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta — Chief Executive Officer Ramesh Swaminathan — Executive Director,...

Aurobindo Pharma Limited (AUROPHARMA) Q3 FY23 Earnings Concall Transcript

● Feb 12, 2023

Aurobindo Pharma Limited (NSE:AUROPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Deepti Thakur — Investor Relations Santhanam Subramanian — Chief Financial...

Fortis Healthcare Q3 FY23; Revenue Increased By 6% Year On Year

● Feb 10, 2023

Fortis Healthcare Limited (NSE: FORTIS) reported a Revenue from Operations of ₹1,559.88 Crores, an increased of 6% growth from the...

Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript

● Feb 9, 2023

Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana — General Manager, Investor Relations...